跳至主要内容
临床试验/NCT03788382
NCT03788382已完成不适用

Failure to Adjuvant Therapy After Pancreatic Resection for Pancreatic Cancer: a Real Life Scenario

Universita di Verona1 个研究点 分布在 1 个国家目标入组 317 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
317
试验地点
1
主要终点
Rate of patients who fail to receive adjuvant therapy and reasons for that

研究概览

简要总结

This study aims to evaluate the rate of patients submitted to pancreatic resection for pancreatic cancer, who fail to access to adjuvant therapy or do not complete adjuvant therapy. The purpose is to give an overview concerning the most frequent conditions and/or reasons associated with failure or omission of adjuvant therapy.

详细描述

This prospective observational study will evaluate all patients submitted to pancreatic resection for pancreatic cancer.

The rate of omission to adjuvant therapy and rate of failure of completion of adjuvant therapy will be evaluated as primary outcomes. As secondary outcomes, survival analyses will be performed to investigate whether these factors influence prognosis, that will be evaluated through a disease free survival analysis at 18-months. Epidemiological and perioperative data will be analyzed to identify conditions associated with the primary outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologic diagnosis of pancreatic cancer

排除标准

  • Non exocrine pancreatic tumors
  • Periampullary malignancies

结局指标

主要结局

Rate of patients who fail to receive adjuvant therapy and reasons for that

时间窗: 6 months

The amount of patients who will not receive adjuvant therapy after pancreatic resection for malignancy (when do indication exists) will be recorded

Rate of patients who fail to complete adjuvant therapy and reasons for that

时间窗: 9 months

The amount of patients who will not complete adjuvant therapy after pancreatic resection for malignancy will be recorded

次要结局

  • Disease free survival of patients enrolled(18 months)

研究者

发起方
Universita di Verona
申办方类型
Other
责任方
Principal Investigator
主要研究者

Salvatore Paiella, MD

Salvatore Paiella, MD, Università di Verona

Universita di Verona

研究点 (1)

Loading locations...

相似试验